• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ephrin A1-Fc 对 EphA2 的结扎抑制胰腺腺癌细胞的侵袭性。

Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness.

作者信息

Duxbury Mark S, Ito Hiromichi, Zinner Michael J, Ashley Stanley W, Whang Edward E

机构信息

Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Biochem Biophys Res Commun. 2004 Aug 6;320(4):1096-102. doi: 10.1016/j.bbrc.2004.06.054.

DOI:10.1016/j.bbrc.2004.06.054
PMID:15249202
Abstract

The Eph tyrosine kinases interact with ligands of the Ephrin family and have diverse cellular functions. EphA2 has been recognized to be an oncoprotein of importance in a range of cancers. Here, we examine the effect of EphA2 overexpression and ligation by chimeric Ephrin A1-Fc on the invasive phenotype of pancreatic adenocarcinoma cells. We show that EphA2 overexpression induces a FAK-dependent increase in MMP-2 expression and invasiveness. EphA2 ligation induces proteosomal degradation of EphA2, attenuates the invasive phenotype, and decreases both FAK phosphorylation and MMP-2 expression. EphA2 appears to represent a rational therapeutic target and ligation by Ephrin A1-Fc is one strategy to modulate levels of this oncoprotein.

摘要

Eph酪氨酸激酶与Ephrin家族的配体相互作用,并具有多种细胞功能。EphA2已被认为是多种癌症中一种重要的癌蛋白。在此,我们研究了EphA2过表达以及嵌合型Ephrin A1-Fc对胰腺腺癌细胞侵袭表型的影响。我们发现EphA2过表达会诱导FAK依赖的MMP-2表达增加和侵袭性增强。EphA2连接会诱导EphA2的蛋白酶体降解,减弱侵袭表型,并降低FAK磷酸化和MMP-2表达。EphA2似乎是一个合理的治疗靶点,通过Ephrin A1-Fc进行连接是调节这种癌蛋白水平的一种策略。

相似文献

1
Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness.Ephrin A1-Fc 对 EphA2 的结扎抑制胰腺腺癌细胞的侵袭性。
Biochem Biophys Res Commun. 2004 Aug 6;320(4):1096-102. doi: 10.1016/j.bbrc.2004.06.054.
2
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation.EphA2激酶的激活会抑制整合素功能并导致粘着斑激酶去磷酸化。
Nat Cell Biol. 2000 Feb;2(2):62-9. doi: 10.1038/35000008.
3
EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas).EphrinA1诱导的细胞骨架重组需要粘着斑激酶(FAK)和p130(cas)。
Nat Cell Biol. 2002 Aug;4(8):565-73. doi: 10.1038/ncb823.
4
Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.Ephrin-A1通过下调EphA2和FAK成为胶质瘤中的负调控因子。
Int J Oncol. 2007 Apr;30(4):865-71.
5
EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.EphA2受体酪氨酸激酶通过磷酸肌醇3激酶介导的Rac1 GTP酶激活来调节内皮细胞迁移和血管组装。
J Cell Sci. 2004 Apr 15;117(Pt 10):2037-49. doi: 10.1242/jcs.01061. Epub 2004 Mar 30.
6
Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases.体内和体外肾缺血再灌注损伤期间EphA2的上调:Src激酶的作用
Am J Physiol Renal Physiol. 2006 Nov;291(5):F960-71. doi: 10.1152/ajprenal.00020.2006. Epub 2006 May 30.
7
Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells via focal adhesion kinase dephosphorylation.激活红细胞生成素产生肝细胞受体 A2 通过去磷酸化粘着斑激酶减轻人输卵管上皮细胞的黏附。
Mol Cell Biochem. 2012 Feb;361(1-2):259-65. doi: 10.1007/s11010-011-1111-z. Epub 2011 Oct 19.
8
Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.EphA受体酪氨酸激酶激活的阻断抑制血管内皮生长因子诱导的血管生成。
Mol Cancer Res. 2002 Nov;1(1):2-11.
9
Inactivation of EphA2 promotes tight junction formation and impairs angiogenesis in brain endothelial cells.EphA2 的失活促进脑内皮细胞紧密连接的形成并损害血管生成。
Microvasc Res. 2011 Sep;82(2):113-21. doi: 10.1016/j.mvr.2011.06.005. Epub 2011 Jun 25.
10
A conditional feedback loop regulates Ras activity through EphA2.一个条件反馈回路通过EphA2调节Ras活性。
Cancer Cell. 2005 Aug;8(2):111-8. doi: 10.1016/j.ccr.2005.07.005.

引用本文的文献

1
Unveiling the therapeutic promise of EphA2 in glioblastoma: a comprehensive review.揭示EphA2在胶质母细胞瘤中的治疗前景:一项全面综述
Discov Oncol. 2024 Sep 27;15(1):501. doi: 10.1007/s12672-024-01380-8.
2
Exploring the potential of EphA2 receptor signaling pathway: a comprehensive review in cancer treatment.探索 EphA2 受体信号通路的潜力:癌症治疗的综合综述。
Mol Biol Rep. 2024 Feb 23;51(1):337. doi: 10.1007/s11033-024-09298-8.
3
Effectiveness of anti-erythropoietin producing Hepatocellular receptor Type-A2 antibody in pancreatic cancer treatment.
抗促红细胞生成素A型2型肝细胞受体抗体在胰腺癌治疗中的有效性。
Heliyon. 2023 Nov 4;9(11):e21774. doi: 10.1016/j.heliyon.2023.e21774. eCollection 2023 Nov.
4
Targeting CDK1 in cancer: mechanisms and implications.靶向癌症中的细胞周期蛋白依赖性激酶1:机制与意义
NPJ Precis Oncol. 2023 Jun 13;7(1):58. doi: 10.1038/s41698-023-00407-7.
5
Targefrin: A Potent Agent Targeting the Ligand Binding Domain of EphA2.靶向 EphA2 配体结合域的有效药物 Targefrin
J Med Chem. 2022 Nov 24;65(22):15443-15456. doi: 10.1021/acs.jmedchem.2c01391. Epub 2022 Nov 4.
6
The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers.环状RNA在血管共选和血管生成拟态中的新作用:癌症抗血管生成治疗的临床见解
Cancer Metastasis Rev. 2022 Mar;41(1):173-191. doi: 10.1007/s10555-021-10000-8. Epub 2021 Oct 18.
7
Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates.EphA2-激动剂-生物素-链霉亲和素偶联物的有效肿瘤靶向。
Molecules. 2021 Jun 17;26(12):3687. doi: 10.3390/molecules26123687.
8
Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model.在原位小鼠模型中,激动型Epha2配体可强烈抑制前列腺癌转移。
Cancers (Basel). 2020 Oct 2;12(10):2854. doi: 10.3390/cancers12102854.
9
Identification of the soluble EphA7-interacting protein Nicalin as a regulator of EphA7 expression.可溶性EphA7相互作用蛋白Nicalin作为EphA7表达调节因子的鉴定。
Mol Cell Biochem. 2021 Jan;476(1):213-220. doi: 10.1007/s11010-020-03898-1. Epub 2020 Sep 10.
10
Dimeric small molecule agonists of EphA2 receptor inhibit glioblastoma cell growth.EphA2 受体二聚小分子激动剂抑制神经胶质瘤细胞生长。
Bioorg Med Chem. 2020 Sep 15;28(18):115656. doi: 10.1016/j.bmc.2020.115656. Epub 2020 Jul 25.